7月 2026
- 首頁
- Rosemont Pharmaceuticals
7月 2026Rosemont Pharmaceuticals的市場佔有率分析
Rosemont has over 50 years of expertise in the development, manufacture and distribution of oral liquid medicines for patients unable to swallow solid medications. At our state-of-the-art manufacturing site in the UK, we produce over 4 million bottles of liquid medicine every year. Our focus on research and development is the key to growth in our portfolio and we continuously invest in our facilities to ensure we have the latest technologies to enhance our capabilities and capacity.
Rosemont Pharmaceuticals(包含公司地區)
查看更多網站流量與參與度資訊- rosemontpharma.com
Rosemont Pharmaceuticals截至 7月 2026 的總收入為 50M - 75M
Rosemont Pharmaceuticals 熱門網域產生的總收入
Rosemont Pharmaceuticals 熱門網域 3 年內的總收入
Rosemont Pharmaceuticals 熱門網域的總收入
Rosemont Pharmaceuticals的熱門網域總造訪量
了解Rosemont Pharmaceuticals市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Rosemont Pharmaceuticals的熱門網域平均造訪時長
分析Rosemont Pharmaceuticals參與度指標。
過去 3 個月平均造訪時長
子公司細目
Rosemont Pharmaceuticals的熱門網域平均頁面瀏覽量
了解Rosemont Pharmaceuticals如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Rosemont Pharmaceuticals
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Rosemontpharma invests into assets: Contract Development Manufacturer Organisation in Greece, Southern Europe, Europe.Rosemont also acquired a Contract Development Manufacturer Organisation in Greece.
8月 1, 2024閱讀更多
新聞Rosemontpharma acquired Pharmadata on Jun 27th '24.Rosemont Pharmaceuticals has acquired Pharma-Data S.A, a privately owned Research and Development Organisation based in Lavrion, Greece.
6月 25, 2024閱讀更多
新聞Rosemontpharma launches 1mg/ml Omeprazole Powder for Oral Suspension an extension to the only range of liquid omeprazole products.Rosemont launch licensed 1mg/ml Omeprazole Powder for Oral Suspension an extension to the only range of liquid omeprazole products, licensed from 1 month.
1月 2, 2024閱讀更多
查看所有Rosemont Pharmaceuticals信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
